Invention Grant
- Patent Title: NK1 antagonists
-
Application No.: US15293962Application Date: 2016-10-14
-
Publication No.: US09969711B2Publication Date: 2018-05-15
- Inventor: Anandan Palani , Xianhai Huang , Dong Xiao , Sunil Paliwal , Hon-Chung Tsui , Michelle Laci Wrobleski , Ashwin U. Rao , Cheng Wang , Sapna S. Shah , Neng-Yang Shih
- Applicant: OPKO Health, Inc.
- Applicant Address: US FL Miami
- Assignee: OPKO Health, Inc.
- Current Assignee: OPKO Health, Inc.
- Current Assignee Address: US FL Miami
- Agency: OPKO Health, Inc.
- Agent Monte R. Browder
- Main IPC: C07D515/00
- IPC: C07D515/00 ; C07D401/04 ; C07D211/66 ; C07D211/76 ; C07D413/04 ; C07D417/04 ; C07D498/20 ; A61K31/451 ; A61K31/4523 ; A61K31/454 ; A61K31/4545 ; A61K45/06 ; C07D211/60 ; A61K31/4178 ; A61K31/573 ; C07D211/56
Abstract:
A compound having the general structure shown in Formula I: or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
Public/Granted literature
- US20170029403A1 NK 1 ANTAGONISTS Public/Granted day:2017-02-02
Information query
